pubmed-article:17826409 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17826409 | lifeskim:mentions | umls-concept:C0019721 | lld:lifeskim |
pubmed-article:17826409 | lifeskim:mentions | umls-concept:C1749467 | lld:lifeskim |
pubmed-article:17826409 | lifeskim:mentions | umls-concept:C0086376 | lld:lifeskim |
pubmed-article:17826409 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:17826409 | lifeskim:mentions | umls-concept:C0341950 | lld:lifeskim |
pubmed-article:17826409 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
pubmed-article:17826409 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:17826409 | pubmed:dateCreated | 2007-9-10 | lld:pubmed |
pubmed-article:17826409 | pubmed:abstractText | Recently, lower maternal plasma human leukocyte antigen (HLA)-G protein levels in preeclampsia (PE) in the first and second trimester was reported. Thus, we sought to evaluate the levels of HLA-G protein in patients with severe PE during the third trimester. | lld:pubmed |
pubmed-article:17826409 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17826409 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17826409 | pubmed:language | eng | lld:pubmed |
pubmed-article:17826409 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17826409 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:17826409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17826409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17826409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17826409 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17826409 | pubmed:month | Sep | lld:pubmed |
pubmed-article:17826409 | pubmed:issn | 1097-6868 | lld:pubmed |
pubmed-article:17826409 | pubmed:author | pubmed-author:SheinerEyalE | lld:pubmed |
pubmed-article:17826409 | pubmed:author | pubmed-author:GeraghtyDanie... | lld:pubmed |
pubmed-article:17826409 | pubmed:author | pubmed-author:HyodoHironobu... | lld:pubmed |
pubmed-article:17826409 | pubmed:author | pubmed-author:GlickmanHagit... | lld:pubmed |
pubmed-article:17826409 | pubmed:author | pubmed-author:HackmonRinatR | lld:pubmed |
pubmed-article:17826409 | pubmed:author | pubmed-author:KoifmanArieA | lld:pubmed |
pubmed-article:17826409 | pubmed:author | pubmed-author:HyoboHirohito... | lld:pubmed |
pubmed-article:17826409 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:17826409 | pubmed:volume | 197 | lld:pubmed |
pubmed-article:17826409 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17826409 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17826409 | pubmed:pagination | 255.e1-5 | lld:pubmed |
pubmed-article:17826409 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:meshHeading | pubmed-meshheading:17826409... | lld:pubmed |
pubmed-article:17826409 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17826409 | pubmed:articleTitle | Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. | lld:pubmed |
pubmed-article:17826409 | pubmed:affiliation | Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. rhackmon@gmail.com | lld:pubmed |
pubmed-article:17826409 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17826409 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:17826409 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:17826409 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |